Additionally, the natural product xanthohumol was unveiled to inhibit the tumorigenic properties of oral squamous cell carcinoma cells via reducing survivin phosphorylation at Thr34 and facilitating ubiquitination, thus resulting in survivin degradation [44]. The gene discussed is BIRC5; the disease is oral cavity squamous cell carcinoma.